ENTRY       hsa04650                    Pathway
NAME        Natural killer cell mediated cytotoxicity - Homo sapiens (human)
DESCRIPTION Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04650  Natural killer cell mediated cytotoxicity
DRUG        D00107  Tacrolimus (USP/INN)
            D00184  Cyclosporine (USP)
            D00745  Interferon alfa-2a (USAN/INN)
            D00746  Interferon beta-1b (USAN/INN)
            D00747  Interferon gamma-1b (USAN/INN)
            D02597  Adalimumab (USAN/INN)
            D02744  Interferon alfacon-1 (USAN/INN)
            D02745  Interferon alfa-2b (USAN)
            D02747  Peginterferon alfa-2a (USAN/INN)
            D02748  Peginterferon alfa-2b (USAN/INN)
            D02811  Alicaforsen sodium (USAN)
            D03304  Interferon beta (JAN)
            D03305  Interferon alfa (NAMALWA) (JP18)
            D03357  Interferon gamma-1a (genetical recombination) (JAN)
            D03441  Certolizumab pegol (USAN/INN)
            D03959  Efalizumab (USAN/INN)
            D04000  Enlimomab (USAN/INN)
            D04045  Erlizumab (USAN/INN)
            D04552  Interferon alfa-n1 (USAN)
            D04553  Interferon alfa-n3 (USAN)
            D04554  Interferon beta-1a (USAN)
            D04687  Lenalidomide (JAN/USAN/INN)
            D05480  Pimecrolimus (JAN/USAN/INN)
            D08556  Tacrolimus (INN)
            D08805  Interferon gamma-n1 (JAN)
            D08844  Albinterferon alfa-2b (USAN)
            D08976  Pomalidomide (JAN/USAN/INN)
            D09033  Voclosporin (JAN/USAN/INN)
            D09813  Lenalidomide hydrate (JAN)
            D10374  Lifitegrast (USAN/INN)
            D10392  Lifitegrast sodium (USAN)
            D10483  Peginterferon beta-1a (USAN/INN)
            D10618  Defactinib (USAN/INN)
            D10983  Ruclosporin (USAN/INN)
            D10993  Tucidinostat (JAN/USAN/INN)
            D11027  Ropeginterferon alfa-2b (INN)
            D12179  Tesnatilimab (USAN/INN)
            D12458  Ozekibart (USAN)
            D12893  Zimistobart
            D12913  Ingitamig (USAN)
            D12953  Sovleplenib (USAN/INN)
            D12954  Sovleplenib acetate (USAN)
            D13057  Bexatamig (USAN/INN)
DBLINKS     GO: 0042267
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        100132285  KIR2DS2; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 [KO:K07982]
            100507436  MICA; MHC class I polypeptide-related sequence A [KO:K07985]
            100528032  KLRC4-KLRK1; KLRC4-KLRK1 readthrough [KO:K06728]
            102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]
            10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
            10870  HCST; hematopoietic cell signal transducer [KO:K07988]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            117157  SH2D1B; SH2 domain containing 1B [KO:K07989]
            124905743  FCGR3B; low affinity immunoglobulin gamma Fc region receptor III-B [KO:K06463]
            135250  RAET1E; retinoic acid early transcript 1E [KO:K07987]
            1437  CSF2; colony stimulating factor 2 [KO:K05427]
            154064  RAET1L; retinoic acid early transcript 1L [KO:K07987]
            2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
            2207  FCER1G; Fc epsilon receptor Ig [KO:K07983]
            2214  FCGR3A; Fc gamma receptor IIIa [KO:K06463]
            2215  FCGR3B; Fc gamma receptor IIIb [KO:K06463]
            22914  KLRK1; killer cell lectin like receptor K1 [KO:K06728]
            2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]
            25759  SHC2; SHC adaptor protein 2 [KO:K17447]
            259197  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
            27040  LAT; linker for activation of T cells [KO:K07362]
            2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
            3002  GZMB; granzyme B [KO:K01353] [EC:3.4.21.79]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
            3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
            3384  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3458  IFNG; interferon gamma [KO:K04687]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]
            353091  RAET1G; retinoic acid early transcript 1G [KO:K07987]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            356  FASLG; Fas ligand [KO:K04389]
            3683  ITGAL; integrin subunit alpha L [KO:K05718]
            3689  ITGB2; integrin subunit beta 2 [KO:K06464]
            369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            3802  KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1 [KO:K07981]
            3803  KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 [KO:K07981]
            3804  KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 [KO:K07981]
            3805  KIR2DL4; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 [KO:K24231]
            3806  KIR2DS1; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 [KO:K07982]
            3808  KIR2DS3; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3 [KO:K07982]
            3809  KIR2DS4; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4 [KO:K07982]
            3810  KIR2DS5; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 [KO:K07982]
            3811  KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 [KO:K07980]
            3812  KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 [KO:K07980]
            3821  KLRC1; killer cell lectin like receptor C1 [KO:K06541]
            3822  KLRC2; killer cell lectin like receptor C2 [KO:K24233]
            3823  KLRC3; killer cell lectin like receptor C3 [KO:K24233]
            3824  KLRD1; killer cell lectin like receptor D1 [KO:K06516]
            3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
            3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]
            3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
            399694  SHC4; SHC adaptor protein 4 [KO:K17449]
            4068  SH2D1A; SH2 domain containing 1A [KO:K07990]
            4277  MICB; MHC class I polypeptide-related sequence B [KO:K07985]
            4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]
            4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]
            4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
            5058  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]
            51744  CD244; CD244 molecule [KO:K06582]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            53358  SHC3; SHC adaptor protein 3 [KO:K17448]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
            5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
            5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
            5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
            5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
            5551  PRF1; perforin 1 [KO:K07818]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            57292  KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A [KO:K24232]
            5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
            5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5880  RAC2; Rac family small GTPase 2 [KO:K07860]
            5881  RAC3; Rac family small GTPase 3 [KO:K07861]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
            6452  SH3BP2; SH3 domain binding protein 2 [KO:K07984]
            6464  SHC1; SHC adaptor protein 1 [KO:K06279]
            6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
            6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7305  TYROBP; transmembrane immune signaling adaptor TYROBP [KO:K07992]
            7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
            7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
            7462  LAT2; linker for activation of T cells family member 2 [KO:K26356]
            7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70 [KO:K07360] [EC:2.7.10.2]
            79465  ULBP3; UL16 binding protein 3 [KO:K07986]
            80328  ULBP2; UL16 binding protein 2 [KO:K07986]
            80329  ULBP1; UL16 binding protein 1 [KO:K07986]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8743  TNFSF10; TNF superfamily member 10 [KO:K04721]
            8795  TNFRSF10B; TNF receptor superfamily member 10b [KO:K04722]
            8797  TNFRSF10A; TNF receptor superfamily member 10a [KO:K04722]
            919  CD247; CD247 molecule [KO:K06453]
            9436  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
            9437  NCR1; natural cytotoxicity triggering receptor 1 [KO:K06741]
            962  CD48; CD48 molecule [KO:K06479]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:15607802
  AUTHORS   Chiesa S, Tomasello E, Vivier E, Vely F.
  TITLE     Coordination of activating and inhibitory signals in natural killer cells.
  JOURNAL   Mol Immunol 42:477-84 (2005)
            DOI:10.1016/j.molimm.2004.07.030
REFERENCE   PMID:16109839
  AUTHORS   Maghazachi AA.
  TITLE     Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  JOURNAL   Pharmacol Rev 57:339-57 (2005)
            DOI:10.1124/pr.57.3.5
REFERENCE   PMID:15567854
  AUTHORS   Vivier E, Nunes JA, Vely F.
  TITLE     Natural killer cell signaling pathways.
  JOURNAL   Science 306:1517-9 (2004)
            DOI:10.1126/science.1103478
REFERENCE   PMID:12205470
  AUTHORS   Colucci F, Di Santo JP, Leibson PJ.
  TITLE     Natural killer cell activation in mice and men: different triggers for similar weapons?
  JOURNAL   Nat Immunol 3:807-13 (2002)
            DOI:10.1038/ni0902-807
REFERENCE   PMID:11062493
  AUTHORS   Perussia B.
  TITLE     Signaling for cytotoxicity.
  JOURNAL   Nat Immunol 1:372-4 (2000)
            DOI:10.1038/80808
REFERENCE   PMID:15607806
  AUTHORS   Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  TITLE     Activation of NK cell cytotoxicity.
  JOURNAL   Mol Immunol 42:501-10 (2005)
            DOI:10.1016/j.molimm.2004.07.034
REFERENCE   PMID:11895890
  AUTHORS   Djeu JY, Jiang K, Wei S.
  TITLE     A view to a kill: signals triggering cytotoxicity.
  JOURNAL   Clin Cancer Res 8:636-40 (2002)
REFERENCE   PMID:12530970
  AUTHORS   Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  TITLE     Nature's TRAIL--on a path to cancer immunotherapy.
  JOURNAL   Immunity 18:1-6 (2003)
            DOI:10.1016/S1074-7613(02)00502-2
REFERENCE   PMID:16177799
  AUTHORS   Colonna M.
  TITLE     Fine-tuning NK cell responses: it's a family affair.
  JOURNAL   Nat Immunol 6:961-2 (2005)
            DOI:10.1038/ni1005-961
REFERENCE   PMID:8942070
  AUTHORS   Bonnema JD, Leibson PJ.
  TITLE     Signal transduction during NK cell activation.
  JOURNAL   Chem Immunol 64:28-43 (1996)
REFERENCE   PMID:16002670
  AUTHORS   Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  TITLE     Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  JOURNAL   J Immunol 175:749-54 (2005)
            DOI:10.4049/jimmunol.175.2.749
REFERENCE   PMID:9143705
  AUTHORS   Rao A, Luo C, Hogan PG.
  TITLE     Transcription factors of the NFAT family: regulation and function.
  JOURNAL   Annu Rev Immunol 15:707-47 (1997)
            DOI:10.1146/annurev.immunol.15.1.707
REFERENCE   PMID:14710949
  AUTHORS   Wu J, Lanier LL.
  TITLE     Natural killer cells and cancer.
  JOURNAL   Adv Cancer Res 90:127-56 (2003)
            DOI:10.1016/S0065-230X(03)90004-2
REFERENCE   PMID:11905813
  AUTHORS   Cerwenka A, Lanier LL.
  TITLE     Natural killer cells, viruses and cancer.
  JOURNAL   Nat Rev Immunol 1:41-9 (2001)
            DOI:10.1038/35095564
REFERENCE   PMID:11836514
  AUTHORS   Blott EJ, Griffiths GM.
  TITLE     Secretory lysosomes.
  JOURNAL   Nat Rev Mol Cell Biol 3:122-31 (2002)
            DOI:10.1038/nrm732
REFERENCE   PMID:12766758
  AUTHORS   Lieberman J.
  TITLE     The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  JOURNAL   Nat Rev Immunol 3:361-70 (2003)
            DOI:10.1038/nri1083
REFERENCE   PMID:12752668
  AUTHORS   Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  TITLE     Granzyme B: a natural born killer.
  JOURNAL   Immunol Rev 193:31-8 (2003)
            DOI:10.1034/j.1600-065X.2003.00044.x
REFERENCE   PMID:15618404
  AUTHORS   Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  TITLE     Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  JOURNAL   Proc Natl Acad Sci U S A 102:123-7 (2005)
            DOI:10.1073/pnas.0405737102
REFERENCE   PMID:9862693
  AUTHORS   Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  TITLE     Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  JOURNAL   J Immunol 161:6648-56 (1998)
REFERENCE   PMID:11390470
  AUTHORS   Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  TITLE     Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  JOURNAL   J Immunol 166:7219-28 (2001)
            DOI:10.4049/jimmunol.166.12.7219
REL_PATHWAY hsa04010  MAPK signaling pathway
            hsa04020  Calcium signaling pathway
            hsa04060  Cytokine-cytokine receptor interaction
            hsa04210  Apoptosis
            hsa04630  JAK-STAT signaling pathway
KO_PATHWAY  ko04650
///
